T cells genetically engineered to express a lab-designed chimeric-antigen receptor, or CAR, offer many patients with blood cancer a new treatment option. But while these T cells may have lifesaving ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback